AstraZeneca PLC Share Price Nasdaq Stockholm
Stocks
AZN
GB0009895292
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
17:00:00 16/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,593.00 SEK | -0.06% |
|
+4.87% | -6.49% |
| 02:55pm | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 09:47am | Daiichi and AstraZeneca cancer drugs secure further approvals in Japan | AN |
| Market Cap | 253B 220B 208B 188B 353B 24,311B 355B 2,478B 958B 12,331B 952B 931B 39,304B | P/E 2026 * |
20.9x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 273B 237B 224B 203B 380B 26,188B 383B 2,669B 1,031B 13,283B 1,025B 1,003B 42,338B | EV / Sales 2026 * |
4.31x | EV / Sales 2027 * | 3.97x |
| Free-Float |
96.63% | Yield 2026 * |
2.04% | Yield 2027 * | 2.18% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
CBOE
| AZN | Real-time | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
CBOE
| AZN | Real-time | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | -0.08% | ||
| 1 week | +4.87% | ||
| Current month | +1.89% | ||
| 1 month | +6.98% | ||
| 3 months | -4.61% | ||
| 6 months | -11.13% | ||
| Current year | -6.49% |
| 1 week | 1,509 |  | 1,619.5 |
| 1 month | 1,479 | | 1,619.5 |
| Current year | 1,467 | | 1,925.5 |
| 1 year | 1,365 | | 1,925.5 |
| 3 years | 1,226 | | 1,925.5 |
| 5 years | 960.3 | | 1,925.5 |
| 10 years | 461.3 | | 1,925.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 30/09/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 31/07/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 05/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 30/09/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 26/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | +4.87% | - | - | 253B | |
| +0.07% | +0.85% | +48.25% | +98.45% | 1,013B | |
| +0.04% | +0.04% | +51.42% | +64.46% | 644B | |
| -0.27% | +4.39% | +21.11% | +70.14% | 465B | |
| +0.53% | +4.26% | +40.29% | +40.53% | 352B | |
| +0.39% | +2.35% | +17.96% | +24.19% | 264B | |
| +0.17% | +4.17% | +6.96% | +13.12% | 253B | |
| -0.04% | -4.05% | +37.47% | +42.66% | 203B | |
| -1.20% | -5.64% | -24.09% | -58.09% | 188B | |
| +0.81% | +1.17% | +32.92% | +94.87% | 181B | |
| Average | -0.00% | -1.08% | +25.81% | +43.37% | 395.97B | |
| Weighted average by Cap. | -0.00% | +0.01% | +34.10% | +59.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.28B 54.84B 51.83B 47.05B 88.19B 6,070B 88.71B 619B 239B 3,079B 238B 232B 9,814B | 66.88B 57.96B 54.78B 49.73B 93.21B 6,416B 93.77B 654B 253B 3,254B 251B 246B 10,373B |
| Net income | 12.07B 10.46B 9.89B 8.98B 16.82B 1,158B 16.92B 118B 45.61B 587B 45.35B 44.34B 1,872B | 13.8B 11.96B 11.31B 10.26B 19.24B 1,324B 19.35B 135B 52.16B 672B 51.85B 50.7B 2,141B |
| Net Debt | 19.56B 16.95B 16.02B 14.55B 27.26B 1,877B 27.43B 191B 73.91B 952B 73.48B 71.85B 3,034B | 11.78B 10.21B 9.65B 8.76B 16.42B 1,130B 16.52B 115B 44.51B 573B 44.26B 43.27B 1,827B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | SEK 1,593.00 | -0.06% | 606,290 |
| 15/09/26 | SEK 1,594.00 | +0.13% | 434,784 |
| 14/09/26 | SEK 1,592.00 | +3.51% | 953,134 |
| 11/09/26 | SEK 1,538.00 | -0.19% | 406,650 |
| 10/09/26 | SEK 1,541.00 | +1.45% | 398,292 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
